Bioequivalence and Interchangeability: Implications for a Provincial Formulary

Table of Contents

1. Bioequivalence and Interchangeability: Implications for a Provincial Formulary
2. Bioequivalence
3. Interchangeability
4. Harmonization Efforts
5. Burden of Proof : The Standard In Vivo Bioequivalence Trial?
6. Population Covered by the Alberta Health Sponsored Drug Programs 1995/96
7. Burden of Proof:The 90% Confidence Interval?
8. Average vs Individual Bioequivalence
9. Number of Brand Name Authorizations for the Alberta Health Sponsored Drug Programs 1993-1997
10. From the Formulary Perspective:

JPPS 1(2) Table of Contents

Author: Eugenia Palylyk-Colwell

Email: epalylyk@ab.bluecross.ca

PDF Version